170.314(a)(2) Drug-Drug, Drug-Allergy Interaction Checks Setup ONC Test Data and Procedure Guidance Create a patient record Test data must be by the customer Identify the combination of medications and medication allergies (examples provided by ICSA Labs) that will be used to generate the notifications Identify 1 user with rights to adjust drug-drug interactions Identify 1 clinical user with rights to prescribe medications Record the allergy Step # Action to Perform Expected Outcome Reference Notes / Deviations TE2.01-2.02 1 Sign on as a user with the ability to adjust the severity Authorized users are permitted to adjust the severity level of drug-drug interactions. level for drug-drug interactions. IN2.01-2.02 Adjust the severity level to allow all drug-drug The severity level is adjusted to allow all drug-drug notifications to be triggered. notifications to be triggered. Sign off after changes have been made. TE2.03 2 Sign on as a user who does not have the ability to adjust The unauthorized user is unable to adjust the drug-drug IN2.01-2.02 the severity level of drug-drug interactions. interactions. Demonstrate how the unauthorized user is unable to adjust the drug-drug interactions. TE1.01-1.04 3 Select a patient. Display the medications and medication The medications and medication allergy have been allergy data entered for the patient. entered for the patient. IN1.01-1.02 TE2.04-2.05 Using CPOE, enter new medication orders. Notifications Upon entering new medication orders, one drug-drug are triggered and displayed for the following: interaction with a low significance, one drug-drug IN2.03 interaction with a high significance, and one drug-allergy One drug-drug interaction with a low significance notification are electronically and automatically (e.g. Protonix and Argesic SA) generated before the order is completed and acted upon, One drug-drug interaction with a high based upon information in the patient’s medication and significance (e.g. Coumadin and Rufen) medication allergy list. One drug-allergy interaction (e.g. Sulfonamides and Bactrim)
170.314(a)(2) Drug-Drug, Drug-Allergy Interaction Checks Setup Create a patient record Identify the combination of medications and medication allergies that will be used to generate the notifications Identify 1 user with rights to adjust drug-drug interactions Identify 1 clinical user with rights to prescribe medications Record the allergy ONC Test Data and Procedure Test data must be by the customer (examples provided by ICSA Labs) Guidance Step # Action to Perform Expected Outcome Reference Notes / Deviations 1 Sign on as a user with the ability to adjust the severity level of drug-drug interactions. Adjust the severity level to allow all drug-drug notifications to be triggered. Sign off after changes have been made. Authorized users are permitted to adjust the severity level for drug-drug interactions. The severity level is adjusted to allow all drug-drug notifications to be triggered. TE2.01-2.02 IN2.01-2.02 2 Sign on as a user who does not have the ability to adjust the severity level of drug-drug interactions. Demonstrate how the unauthorized user is unable to adjust the drug-drug interactions. The unauthorized user is unable to adjust the drug-drug interactions. TE2.03 IN2.01-2.02 3 Select a patient. Display the medications and medication allergy data entered for the patient. Using CPOE, enter new medication orders. Notifications are triggered and displayed for the following: One drug-drug interaction with a low significance (e.g. Protonix and Argesic SA) One drug-drug interaction with a high significance (e.g. Coumadin and Rufen) One drug-allergy interaction (e.g. Sulfonamides and Bactrim) The medications and medication allergy have been entered for the patient. Upon entering new medication orders, one drug-drug interaction with a low significance, one drug-drug interaction with a high significance, and one drug-allergy notification are electronically and automatically generated before the order is completed and acted upon, based upon information in the patient’s medication and medication allergy list. TE1.01-1.04 IN1.01-1.02 TE2.04-2.05 IN2.03